Stay updated with breaking news from Lockbody Technology Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hemophilia Program: Ongoing registrational PRESent-2 and PRESent-3 studies of SerpinPC for the treatment of hemophilia B; PRESent-2 advancing toward interim analysis planned in 2024Orexin Agonist...
Enrollment and dosing ongoing in registrational study of SerpinPC for the treatment of hemophilia BEnrollment and dosing ongoing in Phase 1/2a Stu...
Registered number: 12973576 CENTESSA PHARMACEUTICALS PLC PARENT COMPANY FINANCIAL STATEMENTS FOR THE YEAR ENDED 31... | May 23, 2023
- Strong clinical momentum and cash runway into 2026 to support multiple clinical readouts across pipeline - Advancing registration program for SerpinPC to treat hemophilia B; Enrolling subjects in
– Strong clinical momentum and cash runway into 2026 to support multiple clinical readouts across pipeline – Advancing registration program for SerpinPC to treat hemophilia B; Enrolling... | May 12, 2023